≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Counselling related to sexual attitude, behaviour and orientation

DOID Endpoint Browser

Z21_COUNSELLI_RELATED_SEXUAL_ATTIT_BEHVI_ORIEN

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Z70
  • Cause of death: ICD-10 — Z70

2 out of 7 registries used, show all original rules.

841

4. Check minimum number of events

None

841

5. Include endpoints

None

841

6. Filter based on genotype QC (FinnGen only)

841

Control definitions (FinnGen only)

Control exclude
Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_OTH_CIRCUMSTANC1

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Z7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 841 739 102
Unadjusted period prevalence (%) 0.23 0.25 0.04
Median age at first event (years) 36.35 34.09 52.73

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
737
Matched controls
7370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z70.8
ICD-10 Finland
Other sex counselling
13997.0
323.0
513
*
Z70.9
ICD-10 Finland
Sex counselling, unspecified
1328.7
211.3
196
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
8.4
127.7
340
679
N94.1
ICD-10 Finland
Dyspareunia
25.9
102.1
145
69
Z71.8
ICD-10 Finland
Other specified counselling
5.8
71.6
235
547
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.1
53.1
189
463
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.7
48.5
268
986
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
33.7
47.6
62
20
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
33.6
45.3
59
19
SPAT1249
SPAT
Treatment-related counselling outside office
2.7
36.6
416
2383
N05BA04
ATC
oxazepam; oral
3.2
34.6
228
916
N05AH04
ATC
quetiapine; oral
3.4
33.8
190
676
RD211
NOMESCO Finland
NA
14.2
33.8
58
44
Z70.0
ICD-10 Finland
Counselling related to sexual attitude
+∞
33.6
32
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.9
33.5
79
110
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.7
31.4
285
1390
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
8.1
30.6
71
96
128
Kela drug reimbursment
Cancers of female genital organs
23.4
29.5
42
19
UJF32
NOMESCO Finland
Coloscopy
3.2
29.1
179
672
Z3231
NOMESCO Finland
Registered nurse
2.9
28.7
207
868
P29
ICPC
Psychological sympt/compl other
4.5
28.7
110
279
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
6.8
28.1
73
117
A03FA01
ATC
metoclopramide; systemic, rectal
3.1
27.8
178
688
SPAT1240
SPAT
Therapeutic discussion
3.1
27.4
178
690
N06AX11
ATC
mirtazapine; oral
2.5
26.4
260
1301
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.1
26.2
168
644
N06AX16
ATC
venlafaxine; oral
3.1
25.7
160
602
N02BE01
ATC
paracetamol; systemic, rectal
2.8
25.7
630
4980
WZC30
NOMESCO Finland
Teaching
4.3
25.5
102
268
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
2.5
24.8
249
1249
SPAT1216
SPAT
Assessment of functional ability
4.4
24.7
96
245
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
22.8
178
770
UKC02
NOMESCO Finland
Cystoscopy
4.2
22.4
90
237
P01
ICPC
Feeling anxious/nervous/tense
2.6
22.3
188
848
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.2
22.3
319
1884
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
5.9
21.7
62
113
SPAT1263
SPAT
Sampling
2.1
21.6
378
2431
XX3DW
NOMESCO Finland
Time consuming IT work
4.4
21.4
81
201
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.9
21.1
92
261
R51.80
ICD-10 Finland
Headache
2.8
20.8
156
653
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
20.8
120
423
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.9
20.8
89
248
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.7
20.1
155
659
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
20.1
308
1851
N03AX16
ATC
pregabalin; oral
2.7
20.1
152
640
N03AX12
ATC
gabapentin; oral
3.1
19.9
118
424
HMAK
NOMESCO Finland
NA
2.9
19.5
136
541
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
19.5
271
1557
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.2
19.3
107
366
SPAT1260
SPAT
Consultation of another employee
2.6
19.1
160
713
M79.6
ICD-10 Finland
Pain in limb
2.2
18.8
254
1434
XKD00
NOMESCO Finland
Uroflowmetry
4.5
18.8
69
166
B01AB05
ATC
enoxaparin; parenteral
2.4
18.8
184
891
N02AA05
ATC
oxycodone; systemic
4.4
18.8
71
176
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.8
18.7
133
537
N02AX02
ATC
tramadol; systemic, rectal
2.2
18.7
241
1331
N06AB04
ATC
citalopram; systemic
2.5
18.3
170
800
SPAT1243
SPAT
Psychiatric/psychological examination
4.4
18.2
67
162
J02AC01
ATC
fluconazole; systemic
2.0
18.0
371
2480
N05CF01
ATC
zopiclone; oral
2.3
18.0
193
972
A02BC02
ATC
pantoprazole; systemic
2.0
18.0
404
2792
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
8.2
18.0
40
51
N97.9
ICD-10 Finland
Female infertility, unspecified
3.1
17.9
107
386
H02AB06
ATC
prednisolone; systemic
2.0
17.8
311
1948
D07AD01
ATC
clobetasol; topical
2.8
17.6
121
478
MAX99
NOMESCO Finland
Assistance to normal delivery
0.2
17.6
23
932
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.8
17.6
77
219
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.7
17.4
60
136
N80.9
ICD-10 Finland
Endometriosis, unspecified
5.6
17.3
51
97
N06AB10
ATC
escitalopram; oral
2.2
17.2
213
1149
SPAT1153
SPAT
Removal of sutures
2.2
17.2
200
1048
R50.9
ICD-10 Finland
Fever, unspecified
2.8
17.2
117
458
ULA02
NOMESCO Finland
Kolposcopy
2.6
17.1
136
585
P01AB01
ATC
metronidazole; oral, rectal
2.0
17.1
312
1978
G03GA01
ATC
chorionic gonadotrophin; parenteral
3.6
17.1
80
240
N97.8
ICD-10 Finland
Female infertility of other origin
5.3
17.1
53
107
N06AX21
ATC
duloxetine; oral
3.2
17.0
97
338
LEB00
NOMESCO Finland
Biopsy of vagina
8.4
16.9
37
46
R10.2
ICD-10 Finland
Pelvic and perineal pain
7.1
16.7
41
61
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.5
16.4
137
606
H01CC01
ATC
ganirelix; parenteral
4.5
16.4
59
140
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
8.2
16.2
36
46
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.6
16.2
57
132
SPAT1307
SPAT
Psychosocial counselling and guidance
2.7
16.1
119
490
N06AB06
ATC
sertraline; oral
2.7
16.1
118
483
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
14.0
16.1
27
20
R53
ICD-10 Finland
Malaise and fatigue
2.3
16.0
167
827
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.3
16.0
61
153
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.1
16.0
63
163
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
15.9
228
1300
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
15.8
102
385
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
15.7
156
751
Z00.0
ICD-10 Finland
General medical examination
2.4
15.7
147
689
N06AX12
ATC
bupropion; oral
3.2
15.6
84
281
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.0
15.6
94
341
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.9
15.5
100
375
SPAT1252
SPAT
Overall medication plan or its review
5.5
15.5
46
88
-1
NOMESCO Finland
NA
1.9
15.5
323
2129
R03AC02
ATC
salbutamol; inhalant
1.9
15.4
407
2919
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.9
15.4
103
397
C07AA05
ATC
propranolol; systemic
2.2
15.0
178
932
L02AE02
ATC
leuprorelin; implant, parenteral
6.9
15.0
37
56
A06AC01
ATC
ispaghula (psylla seeds); oral
2.3
15.0
152
742
TLW12
NOMESCO Finland
Insertion of frozen embryo
5.4
14.9
45
88
JAL21
NOMESCO Finland
Laparoscopic excision or destruction of lesion of peritoneum
6.8
14.8
37
57
P99
ICPC
Psychological disorders other
5.2
14.7
46
94
G43.9
ICD-10 Finland
Migraine, unspecified
3.0
14.6
88
318
G03GA05
ATC
follitropin alfa; parenteral
3.7
14.6
66
193
H03AA01
ATC
levothyroxine sodium; systemic
2.1
14.5
182
978
SPAT1312
SPAT
General health counselling
1.9
14.4
303
1989
P03
ICPC
Feeling depressed
2.4
14.4
136
637
L02BG04
ATC
letrozole; oral
3.2
14.3
78
263
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.1
14.3
45
93
A06AD11
ATC
lactulose; oral
3.3
14.2
73
236
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
14.2
82
289
R05
ICPC
Cough
2.1
14.1
185
1010
WX402
NOMESCO Finland
General anaesthesia
2.4
14.1
130
603
SPAT1310
SPAT
Counselling related to known health issue
1.9
14.0
269
1704
H02AB02
ATC
dexamethasone; systemic
3.5
14.0
67
205
M79.1
ICD-10 Finland
Myalgia
2.5
13.8
121
545
N89.5
ICD-10 Finland
Stricture and atresia of vagina
76.6
13.6
15
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
5.2
13.6
42
85
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
13.5
73
245
LAA10
NOMESCO Finland
Percutaneous or transvaginal puncture and recovery of oocyte
4.0
13.5
55
147
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.4
13.4
49
118
R52.1
ICD-10 Finland
Chronic intractable pain
26.3
13.4
18
7
E0000UV
ATC
NA
1.8
13.4
313
2116
TLW00
NOMESCO Finland
Insemination
4.4
13.3
48
115
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
4.1
13.2
51
130
WF003
NOMESCO Finland
Adjuvant radiotherapy
7.3
13.2
31
44
G44.2
ICD-10 Finland
Tension-type headache
2.4
13.2
125
588
S18
ICPC
Laceration/cut
1.9
13.2
236
1450
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.6
13.1
59
172
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.4
13.1
119
545
SPAT1097
SPAT
Recording of ECG
3.0
13.1
78
278
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.7
13.0
91
362
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
19.5
13.0
19
10
F51.0
ICD-10 Finland
Nonorganic insomnia
2.3
12.9
130
628
G03DC03
ATC
lynestrenol; oral
4.6
12.8
44
100
JAH01
NOMESCO Finland
Laparoscopy
4.1
12.8
50
129
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
12.7
263
1696
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
3.6
12.7
57
166
TLW10
NOMESCO Finland
Transfer of fresh embryo
5.0
12.7
40
83
JN3AD
NOMESCO Finland
Abdominal CT examination
3.7
12.7
56
161
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.3
12.7
126
605
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
12.6
103
444
N03AX09
ATC
lamotrigine; oral
3.3
12.6
64
206
N76.3
ICD-10 Finland
Subacute and chronic vulvitis
9.5
12.6
25
27
X04
ICPC
Painful intercourse female
9.5
12.6
25
27
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
24.8
12.5
17
7
R96
ICPC
Asthma
3.0
12.5
72
253
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
12.4
269
1759
R52.2
ICD-10 Finland
Other chronic pain
5.7
12.4
35
64
L03AA13
ATC
pegfilgrastim; parenteral
5.7
12.4
35
64
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
3.2
12.2
64
210
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
38.2
12.2
15
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
12.2
125
607
N94.2
ICD-10 Finland
Vaginismus
16.2
12.2
19
12
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
12.2
574
4800
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
12.7
12.2
21
17
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.2
12.1
37
74
AA1AD
NOMESCO Finland
CT of head and brain
2.4
12.1
106
477
P76
ICPC
Depressive disorder
2.7
12.0
84
331
G47.3
ICD-10 Finland
Sleep apnoea
2.4
12.0
112
518
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
12.0
128
634
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.0
11.9
164
905
B01AB10
ATC
tinzaparin; parenteral
4.2
11.9
45
113
S06.0
ICD-10 Finland
Concussion
2.6
11.7
87
358
ZX120
NOMESCO Finland
Intravenous
3.4
11.7
56
172
A04AA01
ATC
ondansetron; systemic, rectal
3.6
11.7
53
156
X17
ICPC
Pelvis symptom/complaint female
6.7
11.7
29
45
N05AF03
ATC
chlorprothixene; systemic
6.7
11.7
29
45
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
11.6
51
146
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.7
11.6
50
141
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
11.6
100
447
R11
ICD-10 Finland
Nausea and vomiting
2.9
11.5
72
267
N06AX26
ATC
vortioxetine; oral
3.2
11.5
62
208
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.3
11.4
111
524
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.7
11.4
32
58
SPAT1255
SPAT
Intravenous administration of medicine
4.0
11.4
45
118
XKC03
NOMESCO Finland
Water cystometry
6.7
11.4
28
43
N05AX08
ATC
risperidone; systemic
3.5
11.3
53
160
C03CA01
ATC
furosemide; systemic
2.8
11.3
75
289
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.2
11.3
42
104
A02BA02
ATC
ranitidine; systemic
2.4
11.3
98
439
ZY010
NOMESCO Finland
Hospital outpatient
3.3
11.3
57
183
M54.4
ICD-10 Finland
Lumbago with sciatica
2.3
11.3
115
558
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
11.2
76
294
G04BD12
ATC
mirabegron; oral
3.5
11.2
52
156
KMAK
NOMESCO Finland
NA
1.7
11.2
445
3471
Z51.0
ICD-10 Finland
Radiotherapy session
25.5
11.2
15
6
121
Kela drug reimbursment
Severe hypofunction of sexual glands
6.2
11.1
29
48
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
11.1
104
481
N03AG01
ATC
valproic acid; systemic, rectal
3.4
11.1
53
163
MBC33
NOMESCO Finland
Repair of complete rupture of perineum
6.8
11.1
27
41
SPAT1301
SPAT
No procedures
1.8
11.0
235
1516
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
11.0
329
2357
SPAT1131
SPAT
Colonoscopy
6.1
11.0
29
49
SPAT1139
SPAT
Nutrition survey
4.2
11.0
41
102
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
10.8
10.8
20
19
O99.80
ICD-10 Finland
The fear of childbirth
2.5
10.8
87
374
R06AE07
ATC
cetirizine; oral
1.7
10.8
345
2516
JG1JB
NOMESCO Finland
Defekography with X-ray
21.8
10.7
15
7
P74
ICPC
Anxiety disorder/anxiety state
3.1
10.7
58
196
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.9
10.7
29
51
J01DB01
ATC
cefalexin; oral
1.9
10.7
593
5083
LCA06
NOMESCO Finland
Biopsy of endometrium
2.4
10.7
97
445
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
10.6
89
391
N05CF02
ATC
zolpidem; oral
2.2
10.6
121
615
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
4.7
10.6
35
77
A02BC03
ATC
lansoprazole; oral
2.0
10.6
155
875
SPAT1262
SPAT
Handing over of treatment supplies
2.4
10.5
96
440
N80.4
ICD-10 Finland
Endometriosis of rectovaginal septum and vagina
6.3
10.5
27
44
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
10.5
60
210
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
10.5
96
442
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
2.3
10.4
100
469
SBB10
NOMESCO Finland
Teeth copy
2.7
10.4
72
284
A02BC05
ATC
esomeprazole; systemic
1.8
10.2
226
1467
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.4
10.2
48
146
XG474
NOMESCO Finland
Exhalation nntrogen oxide
5.5
10.2
29
54
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.8
10.2
64
239
L43.9
ICD-10 Finland
Lichen planus, unspecified
8.1
10.2
22
28
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
10.2
112
562
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
5.1
10.1
31
63
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.2
10.1
112
563
ZX080
NOMESCO Finland
Image guided radiotherapy
8.6
10.1
21
25
N06AB03
ATC
fluoxetine; oral
2.3
10.1
95
441
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
10.0
198
1239
J01CA08
ATC
pivmecillinam; oral
1.7
10.0
356
2654
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
4.2
10.0
37
92
X01
ICPC
Genital pain female
5.6
9.9
28
52
ZXC96
NOMESCO Finland
Robot assisted procedure
8.3
9.9
21
26
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.4
9.9
87
393
SPAT1359
SPAT
Use of symptom diary
7.2
9.9
23
33
L43.8
ICD-10 Finland
Other lichen planus
9.7
9.8
19
20
R42
ICD-10 Finland
Dizziness and giddiness
2.1
9.8
113
577
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.7
9.8
65
251
N05AX12
ATC
aripiprazole; systemic
3.5
9.7
44
130
N05AH03
ATC
olanzapine; systemic
3.2
9.7
51
169
SPAT1058
SPAT
PEF monitoring instruction
2.8
9.7
64
245
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.0
9.7
137
760
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.0
9.6
38
100
K59.09
ICD-10 Finland
Constipation, unspecified
4.5
9.6
33
76
P25
ICPC
Phase of life problem adult
2.9
9.6
59
215
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
8.5
9.6
20
24
ZX070
NOMESCO Finland
Intensity modified radiotherapy
9.3
9.6
19
21
SPAT1254
SPAT
Administration of medicine
2.2
9.6
99
482
G03GA02
ATC
human menopausal gonadotrophin; parenteral
3.4
9.5
45
138
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
9.5
125
674
L03
ICPC
Low back symptom/complaint
1.8
9.5
177
1082
D07AC01
ATC
betamethasone; topical
1.7
9.5
221
1455
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
9.4
62
235
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
9.4
268
1868
LEE96
NOMESCO Finland
Other repair of vagina
+∞
9.4
9
*
R06.0
ICD-10 Finland
Dyspnoea
2.0
9.4
135
754
N06AB05
ATC
paroxetine; oral
3.0
9.3
54
191
N05BA01
ATC
diazepam; systemic, rectal
2.4
9.3
78
343
J01MA02
ATC
ciprofloxacin; systemic
1.8
9.3
205
1325
N30.9
ICD-10 Finland
Cystitis, unspecified
3.0
9.2
52
179
J01AA02
ATC
doxycycline; systemic
1.6
9.2
477
3899
N06AA09
ATC
amitriptyline; systemic
2.9
9.2
57
210
O70.22
ICD-10 Finland
III degree perineal tear involving one half or more of external anal sphincter thickness torn during childbirth
11.7
9.1
16
14
G03DB01
ATC
dydrogesterone; oral
2.0
9.0
130
726
N81.6
ICD-10 Finland
Rectocele
3.4
8.9
41
124
JAL30
NOMESCO Finland
Omentectomy
10.9
8.8
16
15
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
9.6
8.8
17
18
N80.1
ICD-10 Finland
Endometriosis of ovary
3.4
8.8
41
125
L04AX01
ATC
azathioprine; systemic
3.4
8.8
41
125
M54.5
ICD-10 Finland
Low back pain
1.7
8.8
227
1534
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
4.1
8.7
33
84
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
8.7
326
2433
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
8.7
51
182
XCK00
NOMESCO Finland
Perimetry
3.5
8.7
39
115
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.7
8.7
21
32
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.3
8.6
79
363
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
8.6
129
730
U04
ICPC
Incontinence urine
4.4
8.6
30
71
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.4
8.6
40
122
J01EA01
ATC
trimethoprim; systemic
1.7
8.6
189
1217
O70.21
ICD-10 Finland
III degree perineal tear involving less than one half of external anal sphincter thickness torn during childbirth
10.2
8.6
16
16
M79.7
ICD-10 Finland
Fibromyalgia
3.9
8.5
34
91
R01AD12
ATC
fluticasone furoate; nasal
1.7
8.5
251
1755
R01AD01
ATC
beclometasone; nasal
2.0
8.5
110
587
ZX095
NOMESCO Finland
Combined chemoradiotherapy
27.9
8.5
11
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.4
8.5
40
123
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
20.3
8.5
12
6
K07.60
ICD-10 Finland
Snapping jaw
2.7
8.5
58
229
N06AG02
ATC
moclobemide; oral
4.2
8.5
31
77
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
8.4
167
1039
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.4
8.4
69
299
WX610
NOMESCO Finland
Patient controlled analgesia
12.9
8.4
14
11
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
8.4
43
141
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.7
8.4
57
224
J01FF01
ATC
clindamycin; systemic
1.8
8.4
168
1052
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
5.6
8.3
23
42
SPAT1210
SPAT
Application of cast or individual aid
3.3
8.3
40
125
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
10.9
8.3
15
14
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.5
8.3
28
64
T78.4
ICD-10 Finland
Allergy, unspecified
2.9
8.3
50
183
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
8.3
137
804
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
8.2
282
2048
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
3.7
8.2
34
94
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
8.2
367
2847
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
8.2
71
319
U02
ICPC
Urinary frequency/urgency
2.0
8.2
102
539
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.6
8.1
27
61
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.0
8.1
103
548
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
5.4
8.1
23
44
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
6.0
8.0
21
36
R52.9
ICD-10 Finland
Pain, unspecified
2.6
8.0
59
243
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.5
8.0
27
62
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.6
8.0
58
236
P06
ICPC
Sleep disturbance
2.2
8.0
82
398
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.6
7.9
55
219
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
4.6
7.9
26
58
LAA06
NOMESCO Finland
Transvaginal puncture of ovarian cyst
7.9
7.9
17
22
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.5
7.9
63
269
E000006
ATC
NA
2.5
7.9
58
239
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
7.9
145
880
N05AB03
ATC
perphenazine; systemic, rectal
4.2
7.9
28
68
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.6
7.8
257
1840
N97.0
ICD-10 Finland
Female infertility associated with anovulation
3.1
7.8
42
143
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
7.8
214
1462
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
7.8
240
1692
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
45.5
7.7
9
*
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
45.5
7.7
9
*
A02BC01
ATC
omeprazole; systemic
1.8
7.7
153
950
R30.0
ICD-10 Finland
Dysuria
3.6
7.7
33
95
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
7.7
45
162
N76.0
ICD-10 Finland
Acute vaginitis
2.0
7.6
94
492
C07AB07
ATC
bisoprolol; oral
1.7
7.6
166
1060
N05AA02
ATC
levomepromazine; systemic
4.0
7.6
29
75
A01
ICPC
Pain general/multiple sites
2.7
7.6
52
204
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
6.8
7.6
18
27
JAH00
NOMESCO Finland
Laparotomy
6.8
7.6
18
27
R03DC03
ATC
montelukast; oral
1.9
7.6
118
674
XX1AD
NOMESCO Finland
Other CT-examination
18.6
7.6
11
6
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
7.6
116
657
JN4BD
NOMESCO Finland
Extensive body CT
2.9
7.6
45
163
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
7.6
397
3178
L01
ICPC
Neck symptom/complaint
1.9
7.6
107
591
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
5.8
7.6
20
35
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.6
7.6
32
91
Z12
ICPC
Relationship problem with partner
3.8
7.5
30
81
R03BA01
ATC
beclometasone; inhalant
2.0
7.5
93
486
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.2
7.5
17
24
U01
ICPC
Dysuria/painful urination
2.3
7.5
71
330
D19
ICPC
Teeth/gum symptom/complaint
1.6
7.5
207
1413
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
7.5
37
119
N05BA06
ATC
lorazepam; systemic, sublingual
3.9
7.4
29
77
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
80.9
7.4
8
*
XKX00
NOMESCO Finland
Pelvic floor electromyography
80.9
7.4
8
*
N77.8*L43.9
ICD-10 Finland
Vulvovaginal ulceration and inflammation caused by lichen ruber planus
80.9
7.4
8
*
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
5.7
7.4
20
36
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
13.5
7.4
12
9
M35.7
ICD-10 Finland
Hypermobility syndrome
4.8
7.4
23
49
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
8.5
7.3
15
18
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.9
7.3
43
155
SPAT1211
SPAT
Application of soft bandage
2.3
7.3
63
282
ZXY51
SPAT
NA
+∞
7.3
7
*
N97.4
ICD-10 Finland
Female infertility associated with male factors
3.2
7.3
36
116
F32.1
ICD-10 Finland
Moderate depressive episode
2.3
7.2
67
310
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
7.4
7.2
16
22
F60.9
ICD-10 Finland
Personality disorder, unspecified
4.9
7.2
22
46
A04AA02
ATC
granisetron; systemic, transdermal
3.3
7.2
34
106
M01AE02
ATC
naproxen; oral, rectal
1.5
7.2
407
3298
N39.3
ICD-10 Finland
Stress incontinence
2.7
7.2
49
192
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
7.2
535
4618
F34.1
ICD-10 Finland
Dysthymia
3.2
7.1
35
112
K59.0
ICD-10 Finland
Constipation
3.4
7.1
33
101
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
20.2
7.1
10
5
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
7.1
190
1283
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
8.0
7.1
15
19
D07AA02
ATC
hydrocortisone; topical
1.8
7.1
119
697
F60.5
ICD-10 Finland
Anankastic personality disorder
6.1
7.1
18
30
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
5.7
7.1
19
34
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.7
7.1
19
34
K05.0
ICD-10 Finland
Acute gingivitis
3.5
7.1
31
91
WZA90
NOMESCO Finland
Other doctors statement
1.6
7.1
188
1268
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
8.9
7.1
14
16
ZX114
NOMESCO Finland
Intramuscular
10.2
7.1
13
13
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
4.2
7.1
25
61
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.0
7.0
40
140
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.0
7.0
21
43
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.2
7.0
20
39
ZYC01
NOMESCO Finland
Remote contact by phone
3.1
7.0
36
120
SPAT1229
SPAT
Assessment of need for aid
3.1
7.0
36
120
J05AB01
ATC
aciclovir; systemic
1.7
7.0
142
888
N03AE01
ATC
clonazepam; systemic
3.0
6.9
37
126
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
5.9
6.9
18
31
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
6.9
121
719
R02
ICPC
Shortness of breath/dyspnoea
2.1
6.9
74
364
Z01.9
ICD-10 Finland
Special examination, unspecified
2.9
6.9
40
144
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
2.4
6.8
55
239
Z2446
NOMESCO Finland
Social worker
2.7
6.8
45
175
SFA00
NOMESCO Finland
Small filling
1.9
6.8
94
515
M25.5
ICD-10 Finland
Pain in joint
1.6
6.8
183
1238
E000007
ATC
NA
2.4
6.8
57
252
SPAT1106
SPAT
Acupuncture
11.1
6.8
12
11
N94.8
ICD-10 Finland
Other specified conditions associated with female genital organs and menstrual cycle
9.4
6.8
13
14
XX1XW
NOMESCO Finland
Extensive written report from radiologist
6.2
6.8
17
28
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.7
6.8
45
176
M75.8
ICD-10 Finland
Other shoulder lesions
3.6
6.8
29
84
N04BC09
ATC
rotigotine; transdermal
40.4
6.8
8
*
Z3231
SPAT
NA
40.4
6.8
8
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.8
6.8
43
162
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
16.9
6.8
10
6
R06.5
ICD-10 Finland
Mouth breathing
2.5
6.7
50
206
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
3.9
6.7
26
69
R20.2
ICD-10 Finland
Paraesthesia of skin
2.4
6.7
53
226
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.8
6.7
116
688
N05BE01
ATC
buspirone; oral
5.0
6.7
20
41
N05CD07
ATC
temazepam; oral
2.7
6.7
43
164
N94.6
ICD-10 Finland
Dysmenorrhoea, unspecified
3.0
6.7
36
124
F43.29
ICD-10 Finland
Adaptation disorder UNS
4.3
6.7
23
55
NF1AA
NOMESCO Finland
Hip X-ray examination
3.3
6.7
31
96
X16
ICPC
Vulval symptom/complaint
3.6
6.7
28
80
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.6
6.6
181
1225
N07BB01
ATC
disulfiram; oral
3.7
6.6
27
75
Y96.9
ICD-10 Finland
Unspecified type of accident
6.0
6.6
17
29
N06AA12
ATC
doxepin; systemic
3.9
6.6
25
65
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
6.6
409
3351
JFB00
NOMESCO Finland
Partial resection of small intestine
12.4
6.6
11
9
L29
ICPC
Musculoskeletal sympt/complt other
2.6
6.6
46
184
Z3232
NOMESCO Finland
Midwife
1.8
6.6
120
726
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.6
6.6
28
81
N05BA12
ATC
alprazolam; oral
2.3
6.5
58
264
N06AX22
ATC
agomelatine; oral
3.6
6.5
27
76
M54.2
ICD-10 Finland
Cervicalgia
2.5
6.5
49
206
LBF01
NOMESCO Finland
Laparoscopic perfusion of Fallopian tube
4.3
6.5
22
52
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.6
6.5
27
77
H04.10
ICD-10 Finland
Dry eye syndrome
2.2
6.4
60
280
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
6.4
54
238
Z72.8
ICD-10 Finland
Other problems related to lifestyle
70.4
6.4
7
*
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
70.4
6.4
7
*
SPAT1167
SPAT
Insertion of urinary catheter
7.5
6.4
14
19
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.8
6.4
39
145
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.9
6.4
87
475
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.6
6.4
27
78
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.0
6.4
75
388
355
Kela drug reimbursment
Dienogest
9.4
6.3
12
13
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.7
6.3
41
159
F45.8
ICD-10 Finland
Other somatoform disorders
2.0
6.3
80
426
M01AE01
ATC
ibuprofen; systemic, rectal
1.8
6.2
668
6190
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.8
6.2
24
64
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.5
6.2
20
45
ZXE00
NOMESCO Finland
One hour or less
1.5
6.2
257
1924
J45.1
ICD-10 Finland
Nonallergic asthma
2.5
6.2
44
179
TLC02
NOMESCO Finland
Simple extraction of IUD
2.5
6.2
44
179
A01AB09
ATC
miconazole; local oral
2.4
6.1
52
230
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4.1
6.1
22
55
S29
ICPC
Skin symptom/complaint other
1.9
6.1
92
519
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.1
6.1
31
103
SPAT1360
SPAT
Extensive global examination
2.5
6.1
44
181
L28
ICPC
Limited function/disability (L)
2.2
6.1
57
265
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
12.6
6.1
10
8
F60.7
ICD-10 Finland
Dependent personality disorder
12.6
6.1
10
8
X58
ICD-10 Finland
Exposure to other specified factors
1.9
6.0
90
509
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.7
6.0
24
66
R00.2
ICD-10 Finland
Palpitations
2.3
6.0
54
246
N30.0
ICD-10 Finland
Acute cystitis
1.8
6.0
100
584
F10.20
ICD-10 Finland
Alcohol dependence currently independent
6.1
6.0
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029937) Albumin [Presence] in Urine by Test strip
515
1777
5.90
144.33
5.4
3.0
estimate
0.0
0.0
0.46
252
601
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
561
2690
4.26
88.88
5.3
2.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
440
2013
3.49
69.67
4.4
2.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
610
3433
3.83
68.93
5.3
2.8
estimate
0.0
0.0
0.05
246
590
(3021601) Nitrite [Presence] in Urine by Test strip
610
3446
3.80
68.22
5.8
4.0
estimate
0.0
0.0
0.00
252
608
(3009261) Glucose [Presence] in Urine by Test strip
605
3479
3.63
63.99
5.3
2.9
estimate
0.0
0.0
0.05
252
598
(3021589) Normoblasts [#/volume] in Blood
511
2677
3.32
62.57
11.7
6.6
e9/l
0.0
0.0
0.65
473
2163
(40761536) Microorganisms panel - Urine sediment
212
640
4.09
62.36
5.0
2.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
139
333
4.80
54.90
4.7
3.1
%
0.4
0.5
0.37
22
53
(3017181) Myelocytes/100 leukocytes in Blood
143
363
4.54
52.44
4.7
3.4
%
0.5
1.1
1.24
33
79
(3025159) Blasts/100 leukocytes in Blood
133
324
4.69
51.32
4.9
3.5
%
0.0
0.0
0.80
23
59
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
252
963
3.31
50.80
1.8
1.5
pmol/l
455.3
32781485.8
1.30
220
845
(3021440) Promyelocytes/100 leukocytes in Blood
135
338
4.57
50.29
4.9
3.5
%
0.1
0.2
0.19
27
68
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
120
283
4.78
48.07
2.5
2.6
mmol/l
1.2
1.2
0.18
102
234
(40760892) CBC W Ordered Manual Differential panel - Blood
342
1639
2.83
45.22
5.5
3.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
247
998
3.09
44.59
3.0
2.0
e6/l
7.1
9.5
1.11
235
870
(3026389) Candida sp identified in Specimen by Organism specific culture
68
102
7.17
43.90
2.0
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
339
1754
2.56
36.86
3.7
2.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
311
1565
2.57
35.61
3.1
2.3
ng/l
15.1
20.7
1.67
157
617
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
337
1762
2.52
35.56
4.1
2.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
133
426
3.52
34.57
2.9
2.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
312
1636
2.44
32.04
2.9
2.1
u/l
51.2
57.0
2.01
282
1510
(3026782) Osmolality of Urine
207
893
2.75
31.93
2.8
2.1
mosm/kgh2o
502.3
551.4
2.17
187
743
(3044889) 12 lead EKG panel
546
3654
2.41
31.87
3.6
2.6
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
126
413
3.41
31.47
4.4
2.2
u/ml
40.3
36.9
0.08
120
400
(3015377) Calcium [Moles/volume] in Serum or Plasma
306
1604
2.43
31.32
3.3
2.8
mmol/l
2.3
2.3
0.17
296
1431
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
433
2643
2.32
31.07
6.2
4.5
umol/l
8.4
9.8
5.61
399
2455
(3019150) Specific gravity of Urine by Refractometry
296
1535
2.43
30.96
5.5
3.0
kg/l
1.0
1.0
0.45
67
245
(36304419) Bacteria [Presence] in Urine
269
1346
2.47
30.35
3.2
2.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
635
4601
2.55
30.21
6.2
3.5
e6/l
441.0
534.7
0.09
20
59
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
603
4284
2.44
29.69
8.3
5.6
u/l
71.1
70.4
0.18
575
4001
(3018418) pH of Serum or Plasma
256
1266
2.47
29.51
4.2
2.9
ph
7.4
7.4
0.27
87
210
(3030467) Casts [#/volume] in Urine by Automated count
262
1314
2.44
29.25
3.2
2.4
e6/l
0.2
0.4
2.26
237
959
(3019060) Gas panel - Arterial blood
83
216
4.15
28.94
7.7
4.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
348
1983
2.29
28.86
5.8
3.8
g/l
36.0
37.0
2.59
320
1846
(3002582) Erythrocytes [#/volume] in Urine
277
1450
2.36
27.86
3.3
2.4
e6/l
55.6
106.7
0.40
248
1079
(3032080) INR in Blood by Coagulation assay
300
1633
2.30
27.47
7.9
4.2
inr
1.1
1.0
0.51
182
522
(3023323) Follitropin [Units/volume] in Serum or Plasma
145
570
2.87
26.30
1.4
1.3
iu/l
22.1
18.6
0.68
135
484
(3021387) Prolactin [Units/volume] in Serum or Plasma
144
573
2.83
25.49
1.5
1.6
mu/l
301.5
278.5
0.29
124
504
(3002385) Erythrocyte distribution width [Ratio]
755
6156
3.21
25.07
17.8
10.2
%
13.3
13.3
0.22
743
6011
(3007853) Bacteria identified in Skin by Aerobe culture
150
615
2.75
25.06
2.0
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
713
5654
2.72
24.78
5.8
3.9
pmol/l
14.5
14.3
1.34
677
5237
(3020891) Body temperature
58
129
4.76
24.64
10.7
3.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
631
4768
2.30
23.92
5.4
3.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
194
923
2.43
23.73
3.4
2.1
u/l
7606.0
6805.5
0.12
85
393
(3001122) Ferritin [Mass/volume] in Serum or Plasma
543
3899
2.11
22.99
3.5
2.7
ug/l
79.1
63.4
1.66
502
3673
(3013826) Glucose [Moles/volume] in Serum or Plasma
464
3173
2.03
22.11
5.6
3.4
mmol/l
6.1
6.2
0.19
434
2747
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
321
1925
2.08
22.00
8.0
4.0
mmol/l
1.2
1.2
2.56
296
1739
(3010421) pH of Blood
44
86
5.34
21.67
3.5
1.9
ph
7.4
7.4
1.54
37
69
(3012501) Base excess in Blood by calculation
39
70
5.79
21.02
3.4
1.9
mmol/l
1.6
2.4
1.05
26
39
(3013707) Erythrocyte sedimentation rate by Westergren method
605
4613
2.11
20.64
4.3
3.2
mm/h
9.9
8.7
1.40
578
4294
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
46
98
4.91
20.55
2.0
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
759
6375
2.95
20.54
16.5
7.8
mmol/l
139.4
139.5
0.28
743
6147
(3003396) Base excess in Arterial blood by calculation
101
374
2.93
20.23
9.0
6.3
mmol/l
1.5
0.9
1.05
81
273
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
343
2164
1.99
19.95
6.8
4.6
mmol/l
1.2
1.2
1.93
274
1814
(3013650) Neutrophils [#/volume] in Blood by Automated count
494
3530
1.97
19.91
9.8
7.0
e9/l
3.9
4.0
0.56
464
3096
(3023103) Potassium [Moles/volume] in Serum or Plasma
758
6396
2.88
19.67
16.0
7.9
mmol/l
3.9
3.9
1.29
740
6148
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
85
292
3.13
19.40
1.8
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
307
1878
2.00
19.38
1.4
1.3
u/ml
0.7
1.8
1.89
132
502
(3036481) Cortisol [Moles/volume] in Serum or Plasma
130
564
2.54
19.11
1.8
2.0
nmol/l
368.1
385.5
0.53
119
517
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
76
248
3.27
18.88
1.4
1.5
nmol/l
0.5
0.5
0.08
59
210
(3023368) Bacteria identified in Blood by Culture
194
1012
2.19
18.68
5.0
3.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
92
344
2.88
18.06
1.3
1.2
u/l
11.2
10.1
0.36
85
286
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
366
2421
1.91
18.02
2.6
2.0
nmol/l
74.8
73.1
0.56
347
2242
(3017143) Hepatitis C virus Ab [Presence] in Serum
219
1215
2.09
17.89
1.7
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
314
1987
1.93
17.58
3.7
2.7
e6/l
66.4
63.3
0.04
268
1215
(3022621) pH of Urine by Test strip
110
459
2.61
17.47
3.5
2.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
125
555
2.47
17.43
1.4
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
433
3052
1.86
17.23
6.5
5.0
e9/l
0.5
0.5
1.12
407
2699
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
715
5979
2.31
16.98
13.5
6.8
ml/min/173m2
94.6
95.2
0.34
602
4616
(3006315) Basophils [#/volume] in Blood
432
3057
1.85
16.84
6.5
5.0
e9/l
0.0
0.0
0.45
405
2699
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
217
1225
2.04
16.78
2.0
1.8
u/l
135.8
143.9
0.10
202
1161
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
248
1472
1.97
16.62
2.4
1.9
mg/l
2.8
2.7
0.54
228
1258
(40761535) Cells panel - Urine sediment
98
402
2.63
16.07
6.0
2.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
149
740
2.23
16.00
2.4
2.4
mmol/l
2.4
2.4
1.32
134
637
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
334
2209
1.85
15.94
1.7
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
441
3189
1.81
15.56
6.5
5.2
e9/l
0.2
0.2
0.15
415
2862
(3048689) Calprotectin [Mass/mass] in Stool
183
996
2.07
15.51
2.7
2.3
ug/g
80.7
92.9
0.37
143
767
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
751
6478
2.49
15.50
6.5
4.4
mu/l
1.8
1.9
0.44
719
6126
(3019198) Lymphocytes [#/volume] in Blood
444
3230
1.79
15.24
6.5
4.9
e9/l
1.9
2.0
2.06
421
2914
(40768797) Stomach Pathology biopsy report
137
675
2.23
14.95
1.2
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
100
438
2.46
14.27
7.1
4.3
mmol/l
1.1
1.0
0.61
95
411
(3025941) Bacteria identified in Stool by Culture
97
421
2.47
14.11
1.4
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
174
981
1.98
13.18
1.6
1.3
nmol/l
21.5
21.1
0.12
164
853
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
780
6955
2.68
13.05
16.6
8.3
mg/l
18.6
19.3
0.24
673
5194
(40767503) Oxygen content in Capillary blood by calculation
28
59
4.87
12.67
2.1
1.7
%
16.9
16.8
—
9
25
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
131
677
2.11
12.56
1.5
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
136
713
2.08
12.56
1.9
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
138
731
2.06
12.39
2.6
2.6
ng/l
491.8
520.2
0.09
123
580
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
14
10.15
12.26
1.6
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
14
10.15
12.26
1.6
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
138
734
2.05
12.24
2.7
1.9
umol/l
14.8
15.2
0.26
123
678
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
300
2048
1.72
12.06
4.3
2.7
u/l
27.4
27.3
0.01
283
1950
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
119
602
2.14
12.04
9.1
4.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
68
268
2.67
12.04
2.0
1.8
nmol/l
8.9
9.4
0.17
63
239
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
98
460
2.28
11.92
1.7
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
80
347
2.44
11.63
2.6
2.2
g/l
0.2
0.2
0.34
74
329
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
92
426
2.30
11.55
3.2
3.8
u/l
241.2
223.2
0.62
85
408
(3019309) Folate [Moles/volume] in Red Blood Cells
126
663
2.06
11.48
1.9
1.5
nmol/l
1537.9
1137.6
5.43
106
502
(3004789) Transferrin [Mass/volume] in Serum or Plasma
122
635
2.08
11.44
2.8
1.9
g/l
2.4
2.5
1.45
107
588
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
99
477
2.22
11.30
3.4
3.1
pmol/l
4.5
4.6
0.51
93
425
(40761511) CBC panel - Blood by Automated count
813
7487
3.58
11.29
17.3
8.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
123
648
2.05
11.15
2.5
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
29
71
4.19
10.95
3.9
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
32
85
3.87
10.84
1.1
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
372
2745
1.64
10.81
6.5
5.0
%
0.6
0.7
2.35
355
2554
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
347
2517
1.64
10.79
1.9
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
386
2881
1.63
10.67
6.5
5.2
%
8.0
7.9
0.37
369
2705
(46235355) HIV 1 and 2 tests - Meaningful Use set
403
3043
1.62
10.61
2.2
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
382
2858
1.62
10.36
6.4
4.9
%
2.6
2.7
0.20
366
2651
(4198724)
17
27
6.41
10.30
1.4
1.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
15
8
19.06
10.28
2.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
200
1266
1.76
10.27
2.0
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
158
932
1.86
10.25
1.4
1.3
titre
555.7
525.9
0.06
28
196
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
29
75
3.97
10.19
1.0
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
18
7.89
10.16
1.6
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
20
38
5.37
10.15
1.4
1.4
%
91.8
92.0
0.08
20
38
(3007164) IgA [Mass/volume] in Serum or Plasma
237
1580
1.70
10.07
1.6
1.3
g/l
2.0
2.0
0.06
167
1021
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
145
840
1.88
9.93
1.7
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
696
6088
1.83
9.93
4.0
3.1
mmol/l
5.6
5.5
0.36
652
5686
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
61
252
2.53
9.84
1.9
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
19
7.48
9.72
1.5
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
19
7.48
9.72
2.1
1.6
umol/l
240.2
148.2
—
5
12
(42870588) Differential panel, method unspecified - Blood
267
1851
1.65
9.71
5.3
5.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
187
1182
1.75
9.58
1.3
1.2
iu/ml
14.0
23.9
2.48
54
383
(3002030) Lymphocytes/100 leukocytes in Blood
400
3067
1.58
9.53
6.3
4.9
%
28.9
30.0
1.59
385
2876
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
287
2043
1.61
9.31
2.2
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
178
1125
1.74
9.08
1.3
1.2
u/ml
3.1
9.6
2.04
89
466
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
17
31
5.58
9.00
1.8
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
11
12
9.27
8.99
1.4
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
11
12
9.27
8.99
1.0
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
107
580
1.97
8.91
2.8
1.9
%
24.4
24.6
0.04
84
491
(3005322) IgE [Units/volume] in Serum or Plasma
97
509
2.02
8.85
1.3
1.2
u/ml
183.6
201.2
0.13
91
468
(3028707) Methadone [Presence] in Urine by Screen method
50
198
2.62
8.80
1.8
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
210
1400
1.67
8.77
1.9
1.6
mg/l
1.1
0.9
0.46
154
1029
(3018010) Neutrophils/100 leukocytes in Blood
392
3031
1.55
8.75
5.8
4.7
%
57.1
56.4
0.63
376
2844
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
86
435
2.09
8.66
1.8
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
88
451
2.06
8.56
1.9
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
85
430
2.09
8.56
3.0
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
419
3302
1.54
8.48
5.3
3.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
11
13
8.56
8.48
6.0
7.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
231
1593
1.62
8.39
2.1
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
130
771
1.81
8.19
1.5
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
19
42
4.61
8.15
3.2
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
83
425
2.06
8.09
3.0
2.6
g/l
10.8
10.4
0.35
72
392
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21
51
4.20
8.03
1.6
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
342
2603
1.53
7.99
2.2
1.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
15
28
5.44
7.75
1.9
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
777
7169
2.10
7.73
11.8
7.0
u/l
24.7
23.9
0.69
761
6926
(3020650) Glucose [Presence] in Urine
14
25
5.68
7.56
1.6
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
33
4.92
7.43
1.4
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
15
30
5.07
7.20
1.3
1.2
pg
31.9
32.1
0.06
15
30
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
302
2280
1.51
7.14
2.3
2.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
219
1545
1.56
7.06
5.5
2.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
125
771
1.73
6.85
1.3
1.2
iu/ml
103.9
150.3
1.03
45
314
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
34
805
0.40
6.84
1.5
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
137
871
1.68
6.72
2.5
1.5
%
1.5
1.3
1.40
124
792
(3006653) Thiamine [Moles/volume] in Blood
10
14
7.22
6.71
1.5
1.9
nmol/l
134.5
137.6
—
10
14
(3028026) IgM [Mass/volume] in Serum or Plasma
65
327
2.07
6.66
2.1
1.6
g/l
1.2
1.4
1.16
58
306
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
134
2.68
6.63
1.7
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
35
807
0.41
6.61
1.5
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
24
74
3.31
6.59
2.8
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
35
806
0.41
6.59
1.5
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
35
806
0.41
6.59
1.5
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
20
56
3.63
6.34
1.8
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
609
5351
1.50
6.33
5.0
3.7
mmol/mol
36.9
37.0
0.11
581
5052
(3000494) Fungus identified in Specimen by Culture
105
631
1.76
6.30
1.6
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
55
266
2.14
6.25
2.0
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
52
246
2.19
6.24
3.1
2.5
g/l
65.8
68.0
1.53
47
226
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
52
3.72
6.22
1.7
1.5
—
—
—
0
0
(4035726)
72
388
1.94
6.10
1.5
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
35
4.35
6.04
3.3
2.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
42
865
0.46
5.93
1.5
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
55
277
2.05
5.64
1.3
1.2
u/ml
0.2
0.7
—
6
20
(3019832) Treponema pallidum Ab [Presence] in Serum
296
2308
1.44
5.64
1.9
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
20
61
3.33
5.61
1.6
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
118
756
1.65
5.59
1.2
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
29
4.54
5.52
3.7
2.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
20
62
3.28
5.47
1.7
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
195
1413
1.49
5.40
3.5
2.8
mmol/l
7.6
7.9
0.34
173
1226
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
34
4.17
5.37
3.4
2.4
%
12.6
13.2
—
8
22
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
18
53
3.45
5.33
1.9
1.3
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
11
22
5.05
5.27
1.8
1.3
nmol/l
6.4
5.8
0.14
11
22
(3024354) Oxygen [Partial pressure] in Venous blood
48
237
2.09
5.21
4.6
2.0
kpa
4.4
4.7
0.77
48
231
(3028192) IgG subclass 2 [Mass/volume] in Serum
20
65
3.13
5.09
1.2
1.3
g/l
3.2
2.8
0.36
13
43
(3023511) Choriogonadotropin [Units/volume] in Urine
79
466
1.77
5.06
1.3
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
50
3.45
5.05
1.3
1.1
ratio
1.0
1.1
—
8
21
(3017569) Oxygen content in Arterial blood
9
9
10.09
5.03
6.9
9.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
115
756
1.60
4.91
3.1
2.1
e6/l
0.8
1.0
0.66
85
420
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
104
669
1.63
4.85
2.0
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
829
8013
3.42
4.85
24.6
12.6
e9/l
269.2
263.6
1.57
822
7820
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
243
1879
1.41
4.70
1.9
1.6
pmol/l
96.7
98.2
0.20
139
1024
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
17
53
3.25
4.63
1.0
1.1
miu/ml
1270.6
1460.1
0.32
17
53
(3026361) Erythrocytes [#/volume] in Blood
829
8024
3.32
4.61
24.6
12.6
e12/l
4.4
4.5
3.65
821
7827
(3011288) Drugs identified in Urine by Screen method
65
373
1.80
4.58
1.7
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
75
2.85
4.58
1.6
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
829
8026
3.31
4.57
24.7
12.6
e9/l
6.9
6.8
0.98
820
7818
(3035637) Corticotropin [Mass/volume] in Plasma
18
59
3.10
4.53
1.7
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
52
279
1.92
4.51
5.6
2.6
kpa
5.9
5.9
0.05
52
271
(3000963) Hemoglobin [Mass/volume] in Blood
829
8029
3.28
4.51
24.7
12.6
g/l
132.6
134.0
2.35
823
7934
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
39
3.63
4.50
1.1
1.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
19
65
2.97
4.46
1.2
1.3
g/l
0.3
0.3
0.91
13
43
(4062490)
19
65
2.97
4.46
1.2
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
19
65
2.97
4.46
1.2
1.3
g/l
6.1
5.6
0.21
12
43
(3023183) Ammonium ion [Moles/volume] in Plasma
19
65
2.97
4.46
2.3
2.6
umol/l
31.1
30.3
0.09
13
57
(3027945) Reticulocytes/100 erythrocytes in Blood
65
377
1.78
4.43
3.4
3.0
%
1.7
1.6
0.30
56
336
(3022217) INR in Platelet poor plasma by Coagulation assay
59
334
1.82
4.35
17.5
12.6
inr
1.6
1.1
—
6
45
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
50
269
1.91
4.32
4.6
3.3
ng/l
118.8
68.2
1.35
42
248
(3047352) Trisomy 18 risk [Likelihood] in Fetus
32
648
0.47
4.31
1.5
1.5
—
—
—
0
0
(3012544) pH of Venous blood
52
284
1.89
4.29
5.3
2.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
51
277
1.90
4.28
5.6
2.6
mmol/l
2.6
1.9
0.71
41
208
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
84
2.66
4.26
1.6
1.5
—
—
—
0
0
(3019225) pH of Specimen
15
413
0.35
4.25
3.3
2.9
—
—
—
0
0
(4281824)
16
51
3.18
4.22
1.1
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
339
2807
1.35
4.21
2.0
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
34
667
0.49
4.19
1.6
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
100
1458
0.64
4.15
2.7
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
18
63
2.90
4.08
3.8
5.9
umol/l
337.0
401.2
1.02
18
53
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
28
123
2.32
4.07
1.3
1.3
u/ml
2.5
4.4
0.53
12
40
(3005033) Fetal Nuchal fold Thickness US
33
645
0.49
4.03
1.5
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
70
429
1.69
3.95
1.8
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
184
1395
1.41
3.91
6.6
5.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
179
2.06
3.89
9.2
7.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
39
201
1.99
3.83
1.3
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
8
8.81
3.78
3.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
118
2.24
3.54
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
57
2.84
3.54
1.3
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
39
208
1.92
3.50
2.4
1.6
g/l
1.1
1.2
1.18
39
192
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
18
5.04
3.37
1.2
2.5
umol/l
11.5
14.8
—
9
18
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
37
197
1.92
3.34
2.5
1.6
g/l
0.2
0.2
0.15
37
182
(3049717) Cytology report of Urine Cyto stain
21
89
2.39
3.34
1.7
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
59
2.75
3.33
1.3
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
143
1066
1.41
3.33
3.8
3.2
mg/l
533.1
383.2
0.13
102
690
(1761868) Lipid panel - Serum or Plasma
316
2658
1.30
3.32
2.5
2.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
60
2.70
3.24
2.0
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
72
2.53
3.22
1.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
11
6.41
3.19
3.0
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
528
4767
1.29
3.13
3.3
2.4
u/l
36.9
32.0
0.98
490
4553
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
45
2.92
3.03
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
87
2.33
3.02
3.4
2.3
ug/min
89.5
139.0
0.28
11
52
(44813793)
14
51
2.77
2.99
1.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
82
561
1.51
2.98
1.6
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
49
297
1.69
2.94
2.0
1.5
—
—
—
0
0
(4024509)
13
46
2.85
2.93
1.2
1.3
—
—
—
0
0
(3036489) Thrombin time
39
222
1.79
2.90
2.6
1.5
s
20.1
20.6
0.47
32
188
(3020682) Albumin/Creatinine [Ratio] in Urine
145
1112
1.37
2.85
5.0
3.9
mg/mmol
17.3
10.7
0.64
100
711
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
17
71
2.42
2.81
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
21
97
2.19
2.79
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
81
562
1.49
2.76
1.7
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
42
249
1.72
2.74
10.5
6.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
22
105
2.12
2.70
1.5
1.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
10
6.03
2.70
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
10
6.03
2.70
4.2
3.6
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
10
6.03
2.70
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
10
6.03
2.70
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
10
6.03
2.70
1.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
106
2.10
2.65
1.7
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
81
568
1.47
2.63
1.7
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
49
2.68
2.63
1.4
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
20
93
2.18
2.62
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
81
569
1.47
2.61
1.7
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
15
4.70
2.60
9.4
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
15
4.70
2.60
9.4
2.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
34
193
1.79
2.58
2.4
1.6
%
95.7
93.8
0.17
28
176
(3009343) pH of Capillary blood
34
193
1.79
2.58
2.6
2.4
ph
7.4
7.4
—
5
23
(3000570) Elastase.pancreatic [Mass/mass] in Stool
26
135
1.96
2.58
1.8
1.4
ug/g
309.8
307.0
0.03
17
69
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
24
121
2.01
2.57
1.2
1.3
u/ml
4.7
4.5
—
10
55
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
25
128
1.98
2.57
1.4
1.3
u/ml
137.1
99.6
—
9
27
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
33
186
1.81
2.56
2.4
2.3
mmol/l
1.8
1.3
0.38
20
128
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
11
5.49
2.54
1.7
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
75
522
1.48
2.54
1.7
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
276
2348
1.26
2.52
1.9
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
84
1152
0.70
2.51
1.3
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
40
241
1.69
2.48
2.1
2.6
e9/l
67.6
72.8
0.43
32
175
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
9
26
3.49
2.48
2.9
3.2
u/ml
19.2
113.9
—
9
26
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
21
3.84
2.46
1.3
1.5
ug/l
14.5
19.8
—
8
21
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
21
3.84
2.46
2.0
1.7
umol/l
36.9
31.0
—
8
21
(3023419) Bacteria identified in Sputum by Culture
12
45
2.69
2.46
2.9
3.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
57
377
1.55
2.45
2.4
2.1
ml/min/173m2
65.8
82.0
1.84
27
121
(3024980) IgG subclass 4 [Mass/volume] in Serum
20
96
2.11
2.44
1.4
1.7
g/l
0.5
0.6
0.10
14
71
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
138
1.91
2.43
1.4
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
110
2.03
2.42
1.7
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
77
2.23
2.38
2.2
2.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
58
2.44
2.38
1.3
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
154
1230
1.31
2.30
2.4
2.1
umol/l
2011.8
6568.4
1.40
146
1098
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
49
318
1.57
2.30
3.6
4.3
ug/l
2.9
23.9
0.84
31
244
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
178
1.77
2.29
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
36
216
1.70
2.29
1.8
2.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
64
905
0.68
2.27
1.5
1.4
—
—
—
0
0
(4306422)
22
113
1.97
2.27
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
36
2.80
2.20
1.6
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
8
24
3.36
2.18
2.9
3.1
—
54.8
—
0
6
(42529406) Shigella sp [Presence] in Stool by Culture
31
181
1.74
2.18
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
182
0.38
2.17
2.4
1.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
21
108
1.97
2.17
2.4
2.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
164
0.36
2.16
2.2
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
117
1.90
2.08
1.2
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
7
20
3.52
2.06
1.4
2.0
—
274.8
—
0
5
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
20
3.52
2.06
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
59
410
1.47
2.05
4.2
3.9
%
20.0
22.1
0.51
27
167
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
177
1.72
2.05
1.2
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
15
4.02
2.04
1.5
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
44
2.52
2.01
2.2
4.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
8
26
3.10
2.01
1.1
1.7
mg/l
4.2
2.3
—
8
26
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
112
1.90
1.97
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
34
210
1.65
1.97
1.6
1.6
mmol/l
7.6
7.2
0.37
27
114
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
37
234
1.61
1.96
1.6
2.2
u/l
38.4
38.5
0.01
30
217
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
14
64
2.21
1.95
1.4
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
5
11
4.57
1.94
1.8
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
148
1203
1.28
1.94
1.6
2.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
27
2.98
1.94
7.0
8.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
31
189
1.66
1.90
2.9
1.8
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
25
144
1.76
1.87
1.2
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
9
34
2.66
1.87
1.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
77
575
1.37
1.83
2.8
2.1
umol/l
6.2
5.7
0.14
64
477
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
24
400
0.59
1.82
1.4
1.7
mg/l
4.8
3.1
0.47
13
263
(3033658) Prothrombin time (PT) actual/Normal
155
1282
1.26
1.76
4.2
2.7
%
95.7
97.5
0.39
146
1233
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
18
3.35
1.75
1.5
1.5
ug/l
10.1
7.8
—
6
18
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
34
218
1.58
1.73
1.4
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
21
119
1.78
1.67
1.4
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
19
3.17
1.66
1.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
24
388
0.61
1.64
1.3
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
98
1.86
1.62
1.2
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
29
182
1.61
1.62
1.2
2.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
58
423
1.40
1.60
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
186
1588
1.22
1.58
1.6
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
20
3.01
1.58
1.8
5.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
226
1968
1.20
1.57
2.4
1.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
15
3.35
1.52
2.8
2.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
51
2.17
1.51
1.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
38
260
1.48
1.48
1.1
1.1
u/ml
4.6
3.5
—
5
42
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
266
0.56
1.47
1.9
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
52
2.13
1.45
1.5
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
22
2.74
1.43
2.0
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
39
2.32
1.43
2.0
5.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
39
2.32
1.43
1.0
1.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
46
2.19
1.40
4.6
1.5
%
53.3
62.2
—
10
46
(3034426) Prothrombin time (PT)
6
23
2.62
1.37
1.2
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
17
2.95
1.36
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
28
185
1.53
1.30
1.3
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
18
2.79
1.28
1.2
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
83
1027
0.79
1.28
1.4
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
48
2.10
1.28
1.3
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
55
2.01
1.27
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
160
1380
1.20
1.23
1.6
1.6
mmol/l
1.5
1.3
1.17
123
1212
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
45
2.01
1.23
1.7
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
56
1.98
1.22
1.6
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
56
1.98
1.22
1.1
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
16
93
1.73
1.22
4.6
3.5
u/ml
27.1
27.9
0.02
16
93
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
661
6366
1.18
1.18
4.0
3.1
mmol/l
4.7
4.7
1.05
624
6055
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
33
0.00
1.16
0.0
1.0
—
11.3
—
0
9
(40768795) Lymph node Pathology biopsy report
8
39
2.06
1.15
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
20
126
1.60
1.15
1.3
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
20
2.51
1.15
1.8
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
49
637
0.75
1.12
1.3
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
73
1.79
1.11
1.4
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
23
152
1.53
1.10
1.1
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
46
1.97
1.03
1.1
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
13
75
1.74
1.03
1.4
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
11
60
1.84
1.03
1.2
2.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
35
2.01
1.00
1.6
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
23
156
1.49
0.99
1.2
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
69
1.75
0.97
1.8
3.0
—
850.0
—
0
7
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
30
216
1.40
0.96
1.9
1.9
iu/l
2.2
6.1
3.08
12
76
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
29
2.08
0.89
1.5
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
39
298
1.32
0.89
1.9
1.9
umol/l
5.4
4.2
0.49
24
217
(3029396) Erythrocyte agglutination [Presence] in Blood
12
71
1.70
0.89
2.5
3.2
—
—
—
0
0
(4027681)
10
56
1.80
0.88
1.4
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
56
1.80
0.88
1.1
1.3
nmol/l
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
43
1.87
0.87
2.7
1.9
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
6
30
2.01
0.87
1.0
1.9
—
3.4
—
0
5
(4010399)
47
373
1.28
0.83
1.4
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
51
629
0.80
0.82
2.2
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
32
1.88
0.82
1.0
1.1
iu/ml
128.0
204.1
—
6
32
(3039162) Centromere protein B Ab [Units/volume] in Serum
13
81
1.61
0.81
1.2
1.3
—
32.7
—
0
6
(3024928) Oxygen saturation in Venous blood
11
66
1.68
0.79
3.9
2.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
624
6045
1.13
0.78
3.8
2.8
mmol/l
1.2
1.2
2.22
598
5726
(4146454)
0
26
0.00
0.78
0.0
2.8
—
—
—
0
0
(4268621)
13
82
1.59
0.78
2.2
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
39
305
1.29
0.78
2.2
2.6
ug/l
0.8
0.7
0.10
20
182
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
653
6346
1.13
0.77
3.8
3.1
mmol/l
1.5
1.5
2.59
620
6009
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
7
41
1.71
0.70
1.0
1.0
—
7.9
—
0
8
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
56
465
1.22
0.70
1.4
1.3
miu/ml
265.1
226.5
0.33
31
239
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
25
188
1.34
0.67
2.1
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
95
0.52
0.66
3.6
2.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
28
1.79
0.66
1.6
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
29
1.73
0.64
1.6
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
22
164
1.35
0.63
2.8
1.9
%
12.7
13.1
1.46
22
164
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
121
1.41
0.62
1.2
1.2
—
—
—
0
0
(4094501)
6
101
0.59
0.62
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
690
7038
0.89
0.62
13.7
9.2
%
39.9
39.8
0.27
511
5805
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
156
1.36
0.61
1.2
1.2
—
—
—
0
0
(3013512) EKG study
129
1162
1.13
0.61
2.6
2.4
—
—
—
0
0
(3000492) Spirometry study
76
660
1.17
0.60
1.4
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
148
1.36
0.60
1.2
1.2
u/ml
284.4
222.3
0.45
11
95
(3048929) Epstein Barr virus Ab [Presence] in Serum
43
354
1.23
0.60
1.3
1.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
12
80
1.51
0.60
2.0
1.1
umol/l
4.5
6.4
1.09
12
75
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
52
1.54
0.59
2.0
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
22
285
0.77
0.56
1.1
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
8
55
1.46
0.56
1.6
1.4
pmol/l
393.0
317.8
—
8
40
(3044941) Cell count panel - Synovial fluid
9
60
1.51
0.54
1.3
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
39
1.54
0.53
1.3
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
66
1.52
0.52
1.2
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
656
6423
1.10
0.51
4.2
3.3
mmol/l
2.8
2.8
0.22
622
6060
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
65
1.39
0.50
1.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
65
1.39
0.50
1.1
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
2.3
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
10
67
1.50
0.50
1.2
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
30
244
1.24
0.48
1.1
1.1
u/ml
0.9
1.3
0.29
13
73
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
54
466
1.17
0.48
2.3
1.8
u/l
29.3
31.1
0.27
43
386
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
77
687
1.13
0.45
3.3
2.2
e6/l
4.6
4.0
0.13
46
350
(3004716) Salmonella sp identified in Stool by Organism specific culture
64
564
1.15
0.45
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
133
1438
0.91
0.43
1.6
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
2.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
2.6
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
2.6
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
136
0.73
0.38
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
20
161
1.25
0.37
2.1
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
135
0.74
0.36
1.1
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
71
1.27
0.36
1.3
1.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
71
1.27
0.36
1.1
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
73
1.37
0.34
1.2
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
18
145
1.25
0.34
1.1
1.0
u/ml
2.3
2.0
—
9
81
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
45
1.34
0.34
1.5
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
133
0.75
0.33
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
47
527
0.89
0.32
1.5
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
26
221
1.18
0.31
2.7
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
184
0.81
0.29
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
84
778
1.09
0.28
3.4
2.5
ng/l
85.9
182.8
0.61
38
408
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
76
1.32
0.28
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
76
1.32
0.28
1.3
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
21
177
1.19
0.27
1.1
1.1
u/ml
18.7
4.5
—
8
55
(3010726) Horse dander IgE Ab [Units/volume] in Serum
24
205
1.18
0.27
1.1
1.1
u/ml
1.9
1.8
—
8
39
(3001019) Free T4 and TSH panel - Serum or Plasma
63
679
0.92
0.22
1.5
1.7
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
31
277
1.12
0.21
1.3
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
5.2
—
0
14
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
3.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
3.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
50
1.20
0.19
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
51
1.18
0.19
5.3
2.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
51
1.18
0.19
1.8
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
68
639
1.07
0.18
1.3
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
22
195
1.13
0.17
1.1
1.0
u/ml
5.5
4.2
—
8
55
(3037121) Protein [Mass/volume] in Urine
14
163
0.86
0.17
2.8
3.4
g/l
0.1
0.4
—
9
75
(3002523) Influenza virus A Ag [Presence] in Specimen
16
184
0.87
0.17
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
204
0.88
0.16
1.0
1.1
u/ml
0.2
1.0
—
6
66
(44790049)
8
72
1.11
0.16
1.9
1.5
—
—
—
0
0
(44806118)
8
72
1.11
0.16
1.9
1.5
—
—
—
0
0
(44790048)
8
72
1.11
0.16
1.9
1.5
—
—
—
0
0
(44790047)
8
72
1.11
0.16
1.9
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
328
0.91
0.15
1.8
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
84
1.19
0.14
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
20
222
0.90
0.13
1.8
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
99
0.81
0.13
2.3
1.5
—
—
—
0
0
(4034850)
22
201
1.10
0.11
5.9
7.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
231
1.08
0.10
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
13
115
1.13
0.10
3.2
2.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
218
0.92
0.10
1.0
1.1
u/ml
8.1
6.1
—
7
100
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
15
135
1.11
0.09
3.1
2.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
223
1.08
0.09
1.5
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
55
1.09
0.09
1.0
1.2
u/l
6.3
12.3
—
6
48
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
64
0.78
0.08
2.0
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
64
1.09
0.08
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
634
6309
1.02
0.07
4.2
3.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
13
119
1.09
0.06
1.4
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
18
189
0.95
0.03
2.4
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
18
188
0.96
0.02
1.1
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
207
0.97
0.01
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
265
0.98
0.00
2.6
2.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
18
182
0.99
0.00
1.2
1.3
—
2.8
—
0
26
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
52
517
1.01
0.00
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
36
362
0.99
0.00
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
241
1.00
0.00
1.3
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
97
1.03
0.00
1.2
1.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
15
151
0.99
0.00
1.1
1.1
—
8.7
—
0
15
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
7.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
59
1.02
0.00
1.2
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
2.4
—
0.8
—
0
8
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
71.1
—
0
5
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
1.3
—
2.9
—
0
7
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
59
1.02
0.00
1.2
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
59
1.02
0.00
1.2
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_COUNSELLI_RELATED_SEXUAL_ATTIT_BEHVI_ORIEN – Counselling related to sexual attitude, behaviour and orientation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).